June 2021

Aussie scientists develop breakthrough in IVF treatment

Posted: 11/06/2021 10:00:00 AM
Pioneered by Australian scientists, Genea’s Geri® incubator combined with an updated version of the fluid embryos develop in, has resulted in a staggering 12.2% increase in the number of live births for those struggling to conceive*. The cutting-edge technology is the closest yet to emulating what occurs in the mother’s womb, allowing embryos to grow undisturbed, mirroring the journey in the mother’s fallopian tubes prior to implantation.

Media Contact

Meline Walton
Media & Communications Manager
M: +61 452 433 369
E: meline.walton@genea.com.au

About Genea

Genea is one of Australia’s leading providers for infertility, IVF and other assisted conception treatment with 31 years of experience in the field. The company has long been a fertility pioneer, with research and technologies developed in-house virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. In September 2017, Genea was listed in the Australian Financial Review’s Top 50 Most Innovative Companies List, ranking number 25.